BackRapport Therapeutics Overview

Rapport Therapeutics Total Liabilities

Track Rapport Therapeutics's total liabilities ($26M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$26.09M
↑ 60.85% YoYΔ $9.87M vs prior year quarter

Peer average

Loading

Rapport Therapeutics Total Liabilities History

Loading

Rapport Therapeutics vs. peers: Total Liabilities Comparison

Loading

Rapport Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rapport Therapeutics (RAPP) FAQ

Rapport Therapeutics (RAPP) currently reports a total liabilities of $26M as of March 2026. That compares with $16M in the prior-year period — up 60.8% year over year. Use the charts on this page to explore Rapport Therapeutics's total liabilities history and peer comparisons.

Rapport Therapeutics's total liabilities increased from $16M to $26M — a 60.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rapport Therapeutics reported $26M in total liabilities as of March 2026. That compares with $16M in the prior-year period — up 60.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rapport Therapeutics, and consider following RAPP for alerts when major investors trade the stock.